Lili Wang

发表

Efficacy and safety of nitroglycerin combined with chemotherapy in the elderly patients with advanced non-small cell lung cancer complicated with coronary heart disease

Mingzhi Zhang, Qian Sun, Hong-qiang Guo, 2016 .

Apatinib with etoposide capsules as a third- or further-line therapy for extensive-stage small cell lung cancer: an open-label, multicenter, single-arm phase II trial

Xudong Zhang, Qiming Wang, Tianjiang Ma, 2021, Translational lung cancer research.

Whole-exome sequencing detection of the somatic mutations associated with the tumorigenesis and gefitinib-response of mucoepidermoid carcinomas

Weiqi Wang, B. Dong, Yongjun Guo, 2020 .

Reduction of AZGP1 predicts poor prognosis in esophageal squamous cell carcinoma patients in Northern China

Qiming Wang, Yanru Qin, Yufeng Wu, 2016, OncoTargets and therapy.

Title Reduction of AZGP 1 predicts poor prognosis in esophagealsquamous cell carcinoma patients in northern China

Qiming Wang, Yanru Qin, Yufeng Wu, 2016 .

Cholesterol reduces the sensitivity to platinum-based chemotherapy via upregulating ABCG2 in lung adenocarcinoma.

Hui Zhu, S. Xia, Qiming Wang, 2015, Biochemical and biophysical research communications.

Evolution of Lung Cancer in the Context of Immunotherapy

Qiming Wang, Xuan Wu, Yufeng Wu, 2020, Clinical Medicine Insights. Oncology.

Gefitinib represses JAK-STAT signaling activated by CRTC1-MAML2 fusion in mucoepidermoid carcinoma cells.

B. Dong, Yongjun Guo, J. Qin, 2019, Current cancer drug targets.

Current status of and progress in the treatment of malignant pleural effusion of lung cancer

Qiming Wang, Haiyang Chen, Yufeng Wu, 2023, Frontiers in Oncology.

Depression induces poor prognosis associates with the down-regulation brain derived neurotrophic factor of serum in advanced small cell lung cancer

S. Xia, Qiming Wang, Zelai He, 2016, Oncotarget.

SEMA3B improves the survival of patients with esophageal squamous cell carcinoma by upregulating p53 and p21.

Ming Liu, Hui Zhu, Qiming Wang, 2016, Oncology reports.

Advances in the Treatment of Rare Epidermal Growth Factor Receptor Mutations in Advanced Nonsmall-Cell Lung Cancer

Qiming Wang, Haiyang Chen, Yufeng Wu, 2023, Technology in cancer research & treatment.

Transformation or tumor heterogeneity: Mutations in EGFR, SOX2, TP53, and RB1 persist in the histological rapid conversion from lung adenocarcinoma to small‐cell lung cancer

Zhe Zhang, Lidan Hao, Qiming Wang, 2023, Thoracic cancer.

Sintilimab plus anlotinib as second or further-line therapy for small cell lung cancer: An objective performance trial.

Yuqing Mo, Qiming Wang, Haiyang Chen, 2022, Journal of Clinical Oncology.

Dynamic changes of acquired T790M mutation and small cell lung cancer transformation in a patient with EGFR-mutant adenocarcinoma after first- and third-generation EGFR-TKIs: a case report

Qiming Wang, Xuan Wu, Zhe Zhang, 2020, Translational lung cancer research.

A Trial of the Safety and Efficacy of Chemotherapy Plus Anlotinib vs Chemotherapy Alone as Second- or Third-Line Salvage Treatment for Advanced Non-Small Cell Lung Cancer

Hong Tang, J. Chu, Zheng Yan, 2020, Cancer management and research.

Next-Generation Sequencing Identified a Novel Crizotinib-Sensitive PLB1-ALK Rearrangement in Lung Large-Cell Neuroendocrine Carcinoma.

Jiuzhou Zhao, Yongsen Wang, Qiming Wang, 2020, Clinical lung cancer.

The efficacy and safety of lcotinib in patients with advanced non-small cell lung cancer : compare with gefitinib

Hui Zhu, S. Xia, Qiming Wang, 2016 .

The Riddle of the Sphinx: Progress in Leptomeningeal Metastasis of Non–Small Cell Lung Cancer

Haiyang Chen, Yufeng Wu, Limeng Yu, 2023, Clinical Medicine Insights: Oncology.